Emotion Regulation as a Moderator of Two Different Treatments for Children

Status Recruiting

Clinical Trial Summary

The goal of this randomized controlled trial is to is to test emotion regulation as a moderator of two different treatments for children with Oppositional Defiant Disorder (ODD). The main question it aims to answer is whether treatment gains be increased when children with ODD receive a treatment congruent with their emotion regulation skill problems. Participants will be divided into two groups based on their response patterns; a high emotion dysregulation group and a low emotion dysregulation group. Within each group, children will then be randomly assigned to either a behavioral parent training intervention or a child directed treatment involving problem solving and emotion regulation skills.

Clinical Trial Description

Emotion regulation has been implicated in the development of ODD. Two types of treatment are commonly used for children with ODD, behavioral parent training and child directed cognitive treatments. Parent training focuses on increasing compliance and reducing defiant behaviour while the child directed treatments focus on increasing the child's problem solving skills and emotion regulation. The investigators will assess emotion regulation and emotional lability in children diagnosed with ODD and divide them into two groups based on their response patterns; a high emotion dysregulation group and a low emotion dysregulation group. Within each group, children will then be randomly assigned to either a behavioral parent training intervention or a child directed treatment involving problem solving and emotion regulation skills, which makes it possible to assess the effects of the different interventions for the two distinct groups. Treatment effects will be assessed at pre- and post-treatment as well as at 6 and 18 month follow-up. Comorbid conditions will be tested as moderators. ;

Study Design

Related Conditions & MeSH terms

Attention Deficit and Disruptive Behavior Disorders
Oppositional Defiant Disorder

Clinical Trial Details

NCT number	NCT06194994
Study type	Interventional
Source	University of Iceland
Contact	Urdur Njardvik, PhD
Phone	+354-525-5957
Email	urdurn@hi.is
Status	Recruiting
Phase	N/A
Start date	January 4, 2024
Completion date	December 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03535805` - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances	N/A
Completed	`NCT02485587` - Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents	N/A
Completed	`NCT00819429` - Supplements and Social Skills Intervention Study	N/A
Completed	`NCT01085305` - The Effectiveness of Parent-Child Interaction Therapy (PCIT)	N/A
Completed	`NCT00250354` - A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation	Phase 3
Completed	`NCT05496140` - Remote School-Home Program to Improve Youth Attention and Behavior in Mexican Students	N/A
Completed	`NCT05425966` - Adapting a Web-Based Professional Development for Mexican School Mental Health Providers Delivering Evidence-Based Intervention for ADHD and ODD	N/A
Active, not recruiting	`NCT05049356` - Symptoms and Mechanisms of Child Psychiatric Disorders
Completed	`NCT03698240` - Mindfulness-based Program for Children With Disruptive Behavior Disorder	N/A
Completed	`NCT02766101` - Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges	N/A
Completed	`NCT00404911` - Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth	N/A
Completed	`NCT00192023` - An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).	Phase 3
Completed	`NCT03292848` - Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders	Phase 1
Recruiting	`NCT06373484` - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents	N/A
Recruiting	`NCT05637320` - Big Feelings: A Study on Children's Emotions in Therapy	N/A
Completed	`NCT03729154` - Preschool First Step to Success: An Efficacy Replication Study	N/A
Completed	`NCT02281825` - Correlating Real and Virtual World Behavioral Fluctuations in Adolescence	N/A
Completed	`NCT01822392` - On-line Treatment for Conduct Problems	N/A
Completed	`NCT00406354` - Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany	Phase 4
Completed	`NCT02783560` - Behavioral Sleep Intervention in Children With Disruptive Behaviors	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Emotion Regulation as a Moderator of Two Different Treatments for Children With ODD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms